Global Live Attenuated Influenza Vaccine Laiv Market Research Report 2025(Status and Outlook)
A Live Attenuated Influenza Vaccine (LAIV), also known as the 'nasal spray' or 'intranasal' flu vaccine, is a type of influenza vaccine that is designed to provide immunity against the influenza virus. Unlike traditional injectable influenza vaccines, which contain inactivated (killed) virus particles, LAIV contains a weakened, live influenza virus. This live virus is attenuated, meaning it has been modified to reduce its virulence (ability to cause disease) while still retaining the capacity to stimulate an immune response.
The global Live Attenuated Influenza Vaccine Laiv market size was estimated at USD 8569.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Attenuated Influenza Vaccine Laiv market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Attenuated Influenza Vaccine Laiv market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Attenuated Influenza Vaccine Laiv market.
Global Live Attenuated Influenza Vaccine Laiv Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
Cytiva
BioDiem
FluMist
GSK
ChangChun High & New Technology
BCHT Biotechnology
Market Segmentation (by Type)
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Public Health Agency
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Influenza Vaccine Laiv Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Influenza Vaccine Laiv, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Live Attenuated Influenza Vaccine Laiv market size was estimated at USD 8569.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Attenuated Influenza Vaccine Laiv market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Attenuated Influenza Vaccine Laiv market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Attenuated Influenza Vaccine Laiv market.
Global Live Attenuated Influenza Vaccine Laiv Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Serum Institute
Fluenz Tetra
Cytiva
BioDiem
FluMist
GSK
ChangChun High & New Technology
BCHT Biotechnology
Market Segmentation (by Type)
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Public Health Agency
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Live Attenuated Influenza Vaccine Laiv Market
- Overview of the regional outlook of the Live Attenuated Influenza Vaccine Laiv Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Influenza Vaccine Laiv Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Influenza Vaccine Laiv, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Live Attenuated Influenza Vaccine Laiv
1.2 Key Market Segments
1.2.1 Live Attenuated Influenza Vaccine Laiv Segment by Type
1.2.2 Live Attenuated Influenza Vaccine Laiv Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Live Attenuated Influenza Vaccine Laiv Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Influenza Vaccine Laiv Product Life Cycle
3.3 Global Live Attenuated Influenza Vaccine Laiv Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Influenza Vaccine Laiv Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Influenza Vaccine Laiv Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Attenuated Influenza Vaccine Laiv Market Competitive Situation and Trends
3.8.1 Live Attenuated Influenza Vaccine Laiv Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Attenuated Influenza Vaccine Laiv Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED INFLUENZA VACCINE LAIV INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Influenza Vaccine Laiv Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Influenza Vaccine Laiv Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Attenuated Influenza Vaccine Laiv Market
5.7 ESG Ratings of Leading Companies
6 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Type (2020-2025)
6.4 Global Live Attenuated Influenza Vaccine Laiv Price by Type (2020-2025)
7 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Influenza Vaccine Laiv Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
8 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SALES BY REGION
8.1 Global Live Attenuated Influenza Vaccine Laiv Sales by Region
8.1.1 Global Live Attenuated Influenza Vaccine Laiv Sales by Region
8.1.2 Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region
8.2 Global Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.2.1 Global Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.2.2 Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region
8.3 North America
8.3.1 North America Live Attenuated Influenza Vaccine Laiv Sales by Country
8.3.2 North America Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Attenuated Influenza Vaccine Laiv Sales by Country
8.4.2 Europe Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales by Region
8.5.2 Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Attenuated Influenza Vaccine Laiv Sales by Country
8.6.2 South America Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales by Region
8.7.2 Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET PRODUCTION BY REGION
9.1 Global Production of Live Attenuated Influenza Vaccine Laiv by Region(2020-2025)
9.2 Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Influenza Vaccine Laiv Production
9.4.1 North America Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.4.2 North America Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Influenza Vaccine Laiv Production
9.5.1 Europe Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.5.2 Europe Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Influenza Vaccine Laiv Production (2020-2025)
9.6.1 Japan Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.6.2 Japan Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Influenza Vaccine Laiv Production (2020-2025)
9.7.1 China Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.7.2 China Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Basic Information
10.1.2 Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Overview
10.1.3 Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.1.4 Sanofi Pasteur Business Overview
10.1.5 Sanofi Pasteur SWOT Analysis
10.1.6 Sanofi Pasteur Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Overview
10.2.3 AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 CSL
10.3.1 CSL Basic Information
10.3.2 CSL Live Attenuated Influenza Vaccine Laiv Product Overview
10.3.3 CSL Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.3.4 CSL Business Overview
10.3.5 CSL SWOT Analysis
10.3.6 CSL Recent Developments
10.4 Abbott
10.4.1 Abbott Basic Information
10.4.2 Abbott Live Attenuated Influenza Vaccine Laiv Product Overview
10.4.3 Abbott Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.4.4 Abbott Business Overview
10.4.5 Abbott Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Basic Information
10.5.2 GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Overview
10.5.3 GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 Serum Institute
10.6.1 Serum Institute Basic Information
10.6.2 Serum Institute Live Attenuated Influenza Vaccine Laiv Product Overview
10.6.3 Serum Institute Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.6.4 Serum Institute Business Overview
10.6.5 Serum Institute Recent Developments
10.7 Fluenz Tetra
10.7.1 Fluenz Tetra Basic Information
10.7.2 Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Overview
10.7.3 Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.7.4 Fluenz Tetra Business Overview
10.7.5 Fluenz Tetra Recent Developments
10.8 Cytiva
10.8.1 Cytiva Basic Information
10.8.2 Cytiva Live Attenuated Influenza Vaccine Laiv Product Overview
10.8.3 Cytiva Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.8.4 Cytiva Business Overview
10.8.5 Cytiva Recent Developments
10.9 BioDiem
10.9.1 BioDiem Basic Information
10.9.2 BioDiem Live Attenuated Influenza Vaccine Laiv Product Overview
10.9.3 BioDiem Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.9.4 BioDiem Business Overview
10.9.5 BioDiem Recent Developments
10.10 FluMist
10.10.1 FluMist Basic Information
10.10.2 FluMist Live Attenuated Influenza Vaccine Laiv Product Overview
10.10.3 FluMist Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.10.4 FluMist Business Overview
10.10.5 FluMist Recent Developments
10.11 GSK
10.11.1 GSK Basic Information
10.11.2 GSK Live Attenuated Influenza Vaccine Laiv Product Overview
10.11.3 GSK Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.11.4 GSK Business Overview
10.11.5 GSK Recent Developments
10.12 ChangChun High and New Technology
10.12.1 ChangChun High and New Technology Basic Information
10.12.2 ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Overview
10.12.3 ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.12.4 ChangChun High and New Technology Business Overview
10.12.5 ChangChun High and New Technology Recent Developments
10.13 BCHT Biotechnology
10.13.1 BCHT Biotechnology Basic Information
10.13.2 BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Overview
10.13.3 BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.13.4 BCHT Biotechnology Business Overview
10.13.5 BCHT Biotechnology Recent Developments
11 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET FORECAST BY REGION
11.1 Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast
11.2 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country
11.2.3 Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region
11.2.4 South America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Influenza Vaccine Laiv by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Live Attenuated Influenza Vaccine Laiv by Type (2026-2033)
12.1.2 Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Live Attenuated Influenza Vaccine Laiv by Type (2026-2033)
12.2 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Application (2026-2033)
12.2.1 Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) Forecast by Application
12.2.2 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Live Attenuated Influenza Vaccine Laiv
1.2 Key Market Segments
1.2.1 Live Attenuated Influenza Vaccine Laiv Segment by Type
1.2.2 Live Attenuated Influenza Vaccine Laiv Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Live Attenuated Influenza Vaccine Laiv Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Influenza Vaccine Laiv Product Life Cycle
3.3 Global Live Attenuated Influenza Vaccine Laiv Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Influenza Vaccine Laiv Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Influenza Vaccine Laiv Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Attenuated Influenza Vaccine Laiv Market Competitive Situation and Trends
3.8.1 Live Attenuated Influenza Vaccine Laiv Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Attenuated Influenza Vaccine Laiv Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED INFLUENZA VACCINE LAIV INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Influenza Vaccine Laiv Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Influenza Vaccine Laiv Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Attenuated Influenza Vaccine Laiv Market
5.7 ESG Ratings of Leading Companies
6 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Type (2020-2025)
6.4 Global Live Attenuated Influenza Vaccine Laiv Price by Type (2020-2025)
7 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Influenza Vaccine Laiv Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
8 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET SALES BY REGION
8.1 Global Live Attenuated Influenza Vaccine Laiv Sales by Region
8.1.1 Global Live Attenuated Influenza Vaccine Laiv Sales by Region
8.1.2 Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region
8.2 Global Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.2.1 Global Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.2.2 Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region
8.3 North America
8.3.1 North America Live Attenuated Influenza Vaccine Laiv Sales by Country
8.3.2 North America Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Attenuated Influenza Vaccine Laiv Sales by Country
8.4.2 Europe Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales by Region
8.5.2 Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Attenuated Influenza Vaccine Laiv Sales by Country
8.6.2 South America Live Attenuated Influenza Vaccine Laiv Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales by Region
8.7.2 Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET PRODUCTION BY REGION
9.1 Global Production of Live Attenuated Influenza Vaccine Laiv by Region(2020-2025)
9.2 Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Influenza Vaccine Laiv Production
9.4.1 North America Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.4.2 North America Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Influenza Vaccine Laiv Production
9.5.1 Europe Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.5.2 Europe Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Influenza Vaccine Laiv Production (2020-2025)
9.6.1 Japan Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.6.2 Japan Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Influenza Vaccine Laiv Production (2020-2025)
9.7.1 China Live Attenuated Influenza Vaccine Laiv Production Growth Rate (2020-2025)
9.7.2 China Live Attenuated Influenza Vaccine Laiv Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Basic Information
10.1.2 Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Overview
10.1.3 Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.1.4 Sanofi Pasteur Business Overview
10.1.5 Sanofi Pasteur SWOT Analysis
10.1.6 Sanofi Pasteur Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Overview
10.2.3 AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 CSL
10.3.1 CSL Basic Information
10.3.2 CSL Live Attenuated Influenza Vaccine Laiv Product Overview
10.3.3 CSL Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.3.4 CSL Business Overview
10.3.5 CSL SWOT Analysis
10.3.6 CSL Recent Developments
10.4 Abbott
10.4.1 Abbott Basic Information
10.4.2 Abbott Live Attenuated Influenza Vaccine Laiv Product Overview
10.4.3 Abbott Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.4.4 Abbott Business Overview
10.4.5 Abbott Recent Developments
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Basic Information
10.5.2 GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Overview
10.5.3 GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.5.4 GlaxoSmithKline Business Overview
10.5.5 GlaxoSmithKline Recent Developments
10.6 Serum Institute
10.6.1 Serum Institute Basic Information
10.6.2 Serum Institute Live Attenuated Influenza Vaccine Laiv Product Overview
10.6.3 Serum Institute Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.6.4 Serum Institute Business Overview
10.6.5 Serum Institute Recent Developments
10.7 Fluenz Tetra
10.7.1 Fluenz Tetra Basic Information
10.7.2 Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Overview
10.7.3 Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.7.4 Fluenz Tetra Business Overview
10.7.5 Fluenz Tetra Recent Developments
10.8 Cytiva
10.8.1 Cytiva Basic Information
10.8.2 Cytiva Live Attenuated Influenza Vaccine Laiv Product Overview
10.8.3 Cytiva Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.8.4 Cytiva Business Overview
10.8.5 Cytiva Recent Developments
10.9 BioDiem
10.9.1 BioDiem Basic Information
10.9.2 BioDiem Live Attenuated Influenza Vaccine Laiv Product Overview
10.9.3 BioDiem Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.9.4 BioDiem Business Overview
10.9.5 BioDiem Recent Developments
10.10 FluMist
10.10.1 FluMist Basic Information
10.10.2 FluMist Live Attenuated Influenza Vaccine Laiv Product Overview
10.10.3 FluMist Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.10.4 FluMist Business Overview
10.10.5 FluMist Recent Developments
10.11 GSK
10.11.1 GSK Basic Information
10.11.2 GSK Live Attenuated Influenza Vaccine Laiv Product Overview
10.11.3 GSK Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.11.4 GSK Business Overview
10.11.5 GSK Recent Developments
10.12 ChangChun High and New Technology
10.12.1 ChangChun High and New Technology Basic Information
10.12.2 ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Overview
10.12.3 ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.12.4 ChangChun High and New Technology Business Overview
10.12.5 ChangChun High and New Technology Recent Developments
10.13 BCHT Biotechnology
10.13.1 BCHT Biotechnology Basic Information
10.13.2 BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Overview
10.13.3 BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Market Performance
10.13.4 BCHT Biotechnology Business Overview
10.13.5 BCHT Biotechnology Recent Developments
11 LIVE ATTENUATED INFLUENZA VACCINE LAIV MARKET FORECAST BY REGION
11.1 Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast
11.2 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country
11.2.3 Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region
11.2.4 South America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Influenza Vaccine Laiv by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Live Attenuated Influenza Vaccine Laiv by Type (2026-2033)
12.1.2 Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Live Attenuated Influenza Vaccine Laiv by Type (2026-2033)
12.2 Global Live Attenuated Influenza Vaccine Laiv Market Forecast by Application (2026-2033)
12.2.1 Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) Forecast by Application
12.2.2 Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Influenza Vaccine Laiv Market Size Comparison by Region (M USD)
Table 5. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Influenza Vaccine Laiv Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Influenza Vaccine Laiv Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Influenza Vaccine Laiv as of 2024)
Table 10. Global Market Live Attenuated Influenza Vaccine Laiv Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Live Attenuated Influenza Vaccine Laiv Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Live Attenuated Influenza Vaccine Laiv Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Live Attenuated Influenza Vaccine Laiv Sales by Type (K MT)
Table 26. Global Live Attenuated Influenza Vaccine Laiv Market Size by Type (M USD)
Table 27. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Type (2020-2025)
Table 28. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Type (2020-2025)
Table 29. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) by Type (2020-2025)
Table 30. Global Live Attenuated Influenza Vaccine Laiv Market Size Share by Type (2020-2025)
Table 31. Global Live Attenuated Influenza Vaccine Laiv Price (USD/KG) by Type (2020-2025)
Table 32. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Application
Table 33. Global Live Attenuated Influenza Vaccine Laiv Market Size by Application
Table 34. Global Live Attenuated Influenza Vaccine Laiv Sales by Application (2020-2025) & (K MT)
Table 35. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application (2020-2025)
Table 36. Global Live Attenuated Influenza Vaccine Laiv Market Size by Application (2020-2025) & (M USD)
Table 37. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application (2020-2025)
Table 38. Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
Table 39. Global Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 40. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region (2020-2025)
Table 41. Global Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 42. Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region (2020-2025)
Table 43. North America Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 44. North America Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 46. Europe Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 49. South America Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 50. South America Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 53. Global Live Attenuated Influenza Vaccine Laiv Production (K MT) by Region(2020-2025)
Table 54. Global Live Attenuated Influenza Vaccine Laiv Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Region (2020-2025)
Table 56. Global Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Sanofi Pasteur Basic Information
Table 62. Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Overview
Table 63. Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur SWOT Analysis
Table 66. Sanofi Pasteur Recent Developments
Table 67. AstraZeneca Basic Information
Table 68. AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Overview
Table 69. AstraZeneca Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca SWOT Analysis
Table 72. AstraZeneca Recent Developments
Table 73. CSL Basic Information
Table 74. CSL Live Attenuated Influenza Vaccine Laiv Product Overview
Table 75. CSL Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. CSL Business Overview
Table 77. CSL SWOT Analysis
Table 78. CSL Recent Developments
Table 79. Abbott Basic Information
Table 80. Abbott Live Attenuated Influenza Vaccine Laiv Product Overview
Table 81. Abbott Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Abbott Business Overview
Table 83. Abbott Recent Developments
Table 84. GlaxoSmithKline Basic Information
Table 85. GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Overview
Table 86. GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Recent Developments
Table 89. Serum Institute Basic Information
Table 90. Serum Institute Live Attenuated Influenza Vaccine Laiv Product Overview
Table 91. Serum Institute Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Serum Institute Business Overview
Table 93. Serum Institute Recent Developments
Table 94. Fluenz Tetra Basic Information
Table 95. Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Overview
Table 96. Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Fluenz Tetra Business Overview
Table 98. Fluenz Tetra Recent Developments
Table 99. Cytiva Basic Information
Table 100. Cytiva Live Attenuated Influenza Vaccine Laiv Product Overview
Table 101. Cytiva Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Cytiva Business Overview
Table 103. Cytiva Recent Developments
Table 104. BioDiem Basic Information
Table 105. BioDiem Live Attenuated Influenza Vaccine Laiv Product Overview
Table 106. BioDiem Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. BioDiem Business Overview
Table 108. BioDiem Recent Developments
Table 109. FluMist Basic Information
Table 110. FluMist Live Attenuated Influenza Vaccine Laiv Product Overview
Table 111. FluMist Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. FluMist Business Overview
Table 113. FluMist Recent Developments
Table 114. GSK Basic Information
Table 115. GSK Live Attenuated Influenza Vaccine Laiv Product Overview
Table 116. GSK Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. GSK Business Overview
Table 118. GSK Recent Developments
Table 119. ChangChun High and New Technology Basic Information
Table 120. ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Overview
Table 121. ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. ChangChun High and New Technology Business Overview
Table 123. ChangChun High and New Technology Recent Developments
Table 124. BCHT Biotechnology Basic Information
Table 125. BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Overview
Table 126. BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. BCHT Biotechnology Business Overview
Table 128. BCHT Biotechnology Recent Developments
Table 129. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Live Attenuated Influenza Vaccine Laiv Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Influenza Vaccine Laiv Market Size Comparison by Region (M USD)
Table 5. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Influenza Vaccine Laiv Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Influenza Vaccine Laiv Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Influenza Vaccine Laiv as of 2024)
Table 10. Global Market Live Attenuated Influenza Vaccine Laiv Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Live Attenuated Influenza Vaccine Laiv Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Live Attenuated Influenza Vaccine Laiv Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Live Attenuated Influenza Vaccine Laiv Sales by Type (K MT)
Table 26. Global Live Attenuated Influenza Vaccine Laiv Market Size by Type (M USD)
Table 27. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Type (2020-2025)
Table 28. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Type (2020-2025)
Table 29. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) by Type (2020-2025)
Table 30. Global Live Attenuated Influenza Vaccine Laiv Market Size Share by Type (2020-2025)
Table 31. Global Live Attenuated Influenza Vaccine Laiv Price (USD/KG) by Type (2020-2025)
Table 32. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) by Application
Table 33. Global Live Attenuated Influenza Vaccine Laiv Market Size by Application
Table 34. Global Live Attenuated Influenza Vaccine Laiv Sales by Application (2020-2025) & (K MT)
Table 35. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application (2020-2025)
Table 36. Global Live Attenuated Influenza Vaccine Laiv Market Size by Application (2020-2025) & (M USD)
Table 37. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application (2020-2025)
Table 38. Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
Table 39. Global Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 40. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region (2020-2025)
Table 41. Global Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 42. Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region (2020-2025)
Table 43. North America Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 44. North America Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 46. Europe Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 49. South America Live Attenuated Influenza Vaccine Laiv Sales by Country (2020-2025) & (K MT)
Table 50. South America Live Attenuated Influenza Vaccine Laiv Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size by Region (2020-2025) & (M USD)
Table 53. Global Live Attenuated Influenza Vaccine Laiv Production (K MT) by Region(2020-2025)
Table 54. Global Live Attenuated Influenza Vaccine Laiv Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Live Attenuated Influenza Vaccine Laiv Revenue Market Share by Region (2020-2025)
Table 56. Global Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Live Attenuated Influenza Vaccine Laiv Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Sanofi Pasteur Basic Information
Table 62. Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Product Overview
Table 63. Sanofi Pasteur Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Sanofi Pasteur Business Overview
Table 65. Sanofi Pasteur SWOT Analysis
Table 66. Sanofi Pasteur Recent Developments
Table 67. AstraZeneca Basic Information
Table 68. AstraZeneca Live Attenuated Influenza Vaccine Laiv Product Overview
Table 69. AstraZeneca Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca SWOT Analysis
Table 72. AstraZeneca Recent Developments
Table 73. CSL Basic Information
Table 74. CSL Live Attenuated Influenza Vaccine Laiv Product Overview
Table 75. CSL Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. CSL Business Overview
Table 77. CSL SWOT Analysis
Table 78. CSL Recent Developments
Table 79. Abbott Basic Information
Table 80. Abbott Live Attenuated Influenza Vaccine Laiv Product Overview
Table 81. Abbott Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Abbott Business Overview
Table 83. Abbott Recent Developments
Table 84. GlaxoSmithKline Basic Information
Table 85. GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Product Overview
Table 86. GlaxoSmithKline Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Recent Developments
Table 89. Serum Institute Basic Information
Table 90. Serum Institute Live Attenuated Influenza Vaccine Laiv Product Overview
Table 91. Serum Institute Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Serum Institute Business Overview
Table 93. Serum Institute Recent Developments
Table 94. Fluenz Tetra Basic Information
Table 95. Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Product Overview
Table 96. Fluenz Tetra Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Fluenz Tetra Business Overview
Table 98. Fluenz Tetra Recent Developments
Table 99. Cytiva Basic Information
Table 100. Cytiva Live Attenuated Influenza Vaccine Laiv Product Overview
Table 101. Cytiva Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Cytiva Business Overview
Table 103. Cytiva Recent Developments
Table 104. BioDiem Basic Information
Table 105. BioDiem Live Attenuated Influenza Vaccine Laiv Product Overview
Table 106. BioDiem Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. BioDiem Business Overview
Table 108. BioDiem Recent Developments
Table 109. FluMist Basic Information
Table 110. FluMist Live Attenuated Influenza Vaccine Laiv Product Overview
Table 111. FluMist Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. FluMist Business Overview
Table 113. FluMist Recent Developments
Table 114. GSK Basic Information
Table 115. GSK Live Attenuated Influenza Vaccine Laiv Product Overview
Table 116. GSK Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. GSK Business Overview
Table 118. GSK Recent Developments
Table 119. ChangChun High and New Technology Basic Information
Table 120. ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Product Overview
Table 121. ChangChun High and New Technology Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. ChangChun High and New Technology Business Overview
Table 123. ChangChun High and New Technology Recent Developments
Table 124. BCHT Biotechnology Basic Information
Table 125. BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Product Overview
Table 126. BCHT Biotechnology Live Attenuated Influenza Vaccine Laiv Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. BCHT Biotechnology Business Overview
Table 128. BCHT Biotechnology Recent Developments
Table 129. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Live Attenuated Influenza Vaccine Laiv Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Live Attenuated Influenza Vaccine Laiv
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD), 2024-2033
Figure 5. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) (2020-2033)
Figure 6. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Influenza Vaccine Laiv Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Influenza Vaccine Laiv Product Life Cycle
Figure 13. Live Attenuated Influenza Vaccine Laiv Sales Share by Manufacturers in 2024
Figure 14. Global Live Attenuated Influenza Vaccine Laiv Revenue Share by Manufacturers in 2024
Figure 15. Live Attenuated Influenza Vaccine Laiv Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Live Attenuated Influenza Vaccine Laiv Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Influenza Vaccine Laiv Revenue in 2024
Figure 18. Industry Chain Map of Live Attenuated Influenza Vaccine Laiv
Figure 19. Global Live Attenuated Influenza Vaccine Laiv Market PEST Analysis
Figure 20. Global Live Attenuated Influenza Vaccine Laiv Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Influenza Vaccine Laiv Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Influenza Vaccine Laiv by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Influenza Vaccine Laiv by Type in 2024
Figure 29. Market Size Share of Live Attenuated Influenza Vaccine Laiv by Type (2020-2025)
Figure 30. Market Size Share of Live Attenuated Influenza Vaccine Laiv by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application
Figure 33. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application in 2024
Figure 35. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application in 2024
Figure 37. Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region (2020-2025)
Figure 40. North America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 45. U.S. Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Influenza Vaccine Laiv Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Influenza Vaccine Laiv Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Influenza Vaccine Laiv Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Influenza Vaccine Laiv Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 55. Germany Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region in 2024
Figure 68. China Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 79. South America Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 82. Brazil Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Influenza Vaccine Laiv Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Live Attenuated Influenza Vaccine Laiv Market Share Forecast by Type (2026-2033)
Figure 111. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Application (2026-2033)
Figure 112. Global Live Attenuated Influenza Vaccine Laiv Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Live Attenuated Influenza Vaccine Laiv
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD), 2024-2033
Figure 5. Global Live Attenuated Influenza Vaccine Laiv Market Size (M USD) (2020-2033)
Figure 6. Global Live Attenuated Influenza Vaccine Laiv Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Influenza Vaccine Laiv Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Influenza Vaccine Laiv Product Life Cycle
Figure 13. Live Attenuated Influenza Vaccine Laiv Sales Share by Manufacturers in 2024
Figure 14. Global Live Attenuated Influenza Vaccine Laiv Revenue Share by Manufacturers in 2024
Figure 15. Live Attenuated Influenza Vaccine Laiv Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Live Attenuated Influenza Vaccine Laiv Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Influenza Vaccine Laiv Revenue in 2024
Figure 18. Industry Chain Map of Live Attenuated Influenza Vaccine Laiv
Figure 19. Global Live Attenuated Influenza Vaccine Laiv Market PEST Analysis
Figure 20. Global Live Attenuated Influenza Vaccine Laiv Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Influenza Vaccine Laiv Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Influenza Vaccine Laiv by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Influenza Vaccine Laiv by Type in 2024
Figure 29. Market Size Share of Live Attenuated Influenza Vaccine Laiv by Type (2020-2025)
Figure 30. Market Size Share of Live Attenuated Influenza Vaccine Laiv by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application
Figure 33. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Application in 2024
Figure 35. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Influenza Vaccine Laiv Market Share by Application in 2024
Figure 37. Global Live Attenuated Influenza Vaccine Laiv Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region (2020-2025)
Figure 40. North America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 45. U.S. Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Influenza Vaccine Laiv Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Influenza Vaccine Laiv Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Influenza Vaccine Laiv Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Influenza Vaccine Laiv Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 55. Germany Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region in 2024
Figure 68. China Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 79. South America Live Attenuated Influenza Vaccine Laiv Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Country in 2024
Figure 82. Brazil Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Influenza Vaccine Laiv Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Influenza Vaccine Laiv Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Attenuated Influenza Vaccine Laiv Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Influenza Vaccine Laiv Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Influenza Vaccine Laiv Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Live Attenuated Influenza Vaccine Laiv Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Live Attenuated Influenza Vaccine Laiv Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Live Attenuated Influenza Vaccine Laiv Market Share Forecast by Type (2026-2033)
Figure 111. Global Live Attenuated Influenza Vaccine Laiv Sales Forecast by Application (2026-2033)
Figure 112. Global Live Attenuated Influenza Vaccine Laiv Market Share Forecast by Application (2026-2033)
